Myocarditis & pericarditis are among the most troubling side effects for young people following the experimental COVID-19 jabs.
According to Open VAERS, it has effected 5,222 individuals in the United States as of August 23rd, 2021.
Heart inflammation from the experimental jabs has skewed toward young people.
In Ontario, an alarming number of youth have developed myocarditis/pericarditis following the experimental jab.
Over 100 such cases were reported in individuals under 25 years of age.
Heart inflammation can lead to severe long-term health complications.
Once the heart muscle is damaged, it cannot heal itself.
The damage is permanent.
And who knows how many myocarditis/pericarditis injuries go unreported?
All for a virus healthy young people survive 99.99% of the time.
From the Toronto Sun:
A report quietly released last week by Public Health Ontario (PHO) tallies the number of people in the province who have presented to hospital with heart inflammation following mRNA vaccination, and it skews heavily towards young people.
As of Aug. 7, there were 106 incidents of myocarditis/pericarditis in Ontarians under the age of 25. That’s slightly more than half of the total of all such incidents.
Broken down further, 31 of these cases were in 12- to 17-year-olds and 75 were in 18- to 24-year-olds. The vast majority — 80% — were in males.
The report explains that PHO issued a directive in June for public health units to increase their surveillance of this side effect following reports from the United States and Israel of similar concerns unfolding in those countries.
“The reporting rate of myocarditis/pericarditis was higher following the second dose of mRNA vaccine than after the first, particularly for those receiving the Moderna vaccine as the second dose of the series (regardless of the product for the first dose),” the report explains.
PHO adds that the reporting rate for heart inflammation in those 18-24 was seven times higher with Moderna than with Pfizer. (The only vaccine currently used for 12- to 17-year-olds in Ontario is Pfizer.)
While PHO initially worked with reports of 314 such incidents, upon further investigation they narrowed that number down to just over 200.
Read further details from Public Health Ontario:
- Since the start of the COVID-19 immunization program in Ontario, there have been 314 reports
of myocarditis or pericarditis following receipt of COVID-19 mRNA vaccines in Ontario.
- Of those, 204 reports of myocarditis/pericarditis met the Brighton Collaboration case definition
levels of diagnostic certainty 1, 2 or 3 for myocarditis or pericarditis and are subsequently
included in the remainder of the analysis.5,6
- Among the 204 reports, 79.9% occurred in males and 69.6% occurred following second
- The reporting rate of myocarditis/pericarditis was higher following the second dose of mRNA
vaccine than after the first dose, particularly for those receiving the Moderna vaccine as the
second dose of the series (regardless of the product received for the first dose).
- The reporting rate for the Pfizer-BioNTech vaccine was 6.4 per million doses administered
following first dose and 8.7 per million doses administered following second dose, for all
age groups and genders combined.
- The reporting rate for the Moderna vaccine was 6.6 per million doses administered
following first dose and 28.2 per million doses administered following second dose, for all
age groups and genders combined.
- The highest reporting rate of myocarditis/pericarditis was observed in males aged 18-24 years
following second dose.
- The reporting rate in this group following the Pfizer-BioNTech vaccine as second dose was
37.4 per million doses and was 263.2 per million following the Moderna vaccine as second
- Similar patterns in reporting rates were observed when the analysis was restricted to individuals
who received their first dose on or after June 1st, 2021, to account for enhanced awareness and
surveillance of myocarditis/pericarditis that began in June and a number of other programmatic
factors that occurred at that time.
- Myocarditis/pericarditis following COVID-19 mRNA vaccines remains a rare AEFI (defined by the
Canadian Immunization Guide as occurring at frequency of 0.01% to less than 0.1%), even
among the age groups where the highest rates of this event have been observed.
Young, healthy people with zero underlying conditions have no risk of severe complications from COVID-19.
They have no business taking these experimental injections.
The risk from the jabs is far greater than the benefit for young people.
Due to the effective treatments censored by the mainstream media and medical overlords, I’d make that argument for every age cohort.
Yet, the desperation to push the experimental injections is higher than ever.